These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34508913)

  • 1. Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection.
    Huang CE; Chang JJ; Wu YY; Huang SH; Chen WM; Hsu CC; Lu CH; Hung CH; Shi CS; Lee KD; Chen CC; Chen MC
    Biomed J; 2022 Oct; 45(5):788-797. PubMed ID: 34508913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection.
    Huang CE; Chang JJ; Chen CC; Wang YH; Lu CH; Chen YY; Wang TY; Chen MC
    Blood Coagul Fibrinolysis; 2023 Jul; 34(5):310-318. PubMed ID: 37395218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection.
    Wang CS; Yao WJ; Wang ST; Chang TT; Chou P
    Clin Infect Dis; 2004 Sep; 39(6):790-6. PubMed ID: 15472809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.
    Yan LB; Rao HY; Ma YJ; Bai L; Chen EQ; Du LY; Yang RF; Wei L; Tang H;
    BMJ Open; 2016 Oct; 6(10):e012016. PubMed ID: 27733412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and C virus infection in Crohn's disease.
    Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
    Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence.
    Mohamed EA; Giama NH; Abdalla AO; Shaleh HM; Oseini AM; Ali HA; Ahmed F; Taha W; Ahmed Mohammed H; Cvinar J; Waaeys IA; Ali H; Allotey LK; Ali AO; Mohamed SA; Harmsen WS; Ahmmad EM; Bajwa NA; Afgarshe MD; Shire AM; Balls-Berry JE; Roberts LR
    World J Gastroenterol; 2022 Sep; 28(35):5217-5229. PubMed ID: 36188718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with dual infection by hepatitis B and C viruses.
    Zarski JP; Bohn B; Bastie A; Pawlotsky JM; Baud M; Bost-Bezeaux F; Tran van Nhieu J; Seigneurin JM; Buffet C; Dhumeaux D
    J Hepatol; 1998 Jan; 28(1):27-33. PubMed ID: 9537860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact of hepatitis B, C virus infection on renal transplantation.
    Lee WC; Shu KH; Cheng CH; Wu MJ; Chen CH; Lian JC
    Am J Nephrol; 2001; 21(4):300-6. PubMed ID: 11509802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.